» Articles » PMID: 30341718

Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study

Overview
Publisher Springer
Date 2018 Oct 21
PMID 30341718
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) exert their therapeutic capability through a variety of bioactive substances, including trophic factors, microRNAs, and extracellular vesicles (EVs) in infarcted tissues. We therefore hypothesized that MSC-derived EVs (MSC-EVs) possess therapeutic molecules similar to MSCs. Moreover, given their nature as nanosized and lipid-shielded particles, the intravenous infusion of MSC-EVs would be advantageous over MSCs as a safer therapeutic approach. In this study, we investigated the biodistribution, therapeutic efficacy, and mode of action of MSC-EVs in a rat stroke model. MSC-EVs successfully stimulated neurogenesis and angiogenesis in vivo. When compared to the MSC-treated group, rats treated with MSC-EVs exhibited greater behavioral improvements than the control group (p < 0.05). Our biodistribution study using fluorescence-labeled MSC-EVs and MSCs demonstrated that the amounts of MSC-EVs in the infarcted hemisphere increased in a dose-dependent manner, and were rarely found in the lung and liver. In addition, MSC-EVs were highly inclusive of various proteins and microRNAs (miRNAs) associated with neurogenesis and/or angiogenesis compared to fibro-EVs. We further analyzed those miRNAs and found that miRNA-184 and miRNA-210 were essential for promoting neurogenesis and angiogenesis of MSC-EVs, respectively. MSC-EVs represent an ideal alternative to MSCs for stroke treatment, with similar medicinal capacity but an improved safety profile that overcomes cell-associated limitations in stem cell therapy.

Citing Articles

The Role of Extracellular Vesicles in Aging and Age-Related Disorders.

Ganesh B, Padinjarathil H, Rajendran R, Ramani P, Gangadaran P, Ahn B Antioxidants (Basel). 2025; 14(2).

PMID: 40002364 PMC: 11851802. DOI: 10.3390/antiox14020177.


Mesenchymal stem cell exosome therapy: current research status in the treatment of neurodegenerative diseases and the possibility of reversing normal brain aging.

Quan J, Liu Q, Li P, Yang Z, Zhang Y, Zhao F Stem Cell Res Ther. 2025; 16(1):76.

PMID: 39985030 PMC: 11846194. DOI: 10.1186/s13287-025-04160-5.


Current Development of Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Zheng B, Wang X, Guo M, Tzeng C Cell Transplant. 2025; 34:9636897241297623.

PMID: 39874070 PMC: 11775985. DOI: 10.1177/09636897241297623.


Exosomes derived from highly scalable and regenerative human progenitor cells promote functional improvement in a rat model of ischemic stroke.

Lee J, Var S, Chen D, Natera-Rodriguez D, Hassanipour M, West M bioRxiv. 2025; .

PMID: 39829810 PMC: 11741374. DOI: 10.1101/2025.01.07.631793.


Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery.

Tenchov R, Hughes K, Ganesan M, Iyer K, Ralhan K, Lotti Diaz L ACS Nano. 2025; 19(4):4011-4038.

PMID: 39823199 PMC: 11803921. DOI: 10.1021/acsnano.4c09566.


References
1.
Ratajczak M, Kucia M, Jadczyk T, Greco N, Wojakowski W, Tendera M . Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?. Leukemia. 2011; 26(6):1166-73. DOI: 10.1038/leu.2011.389. View

2.
Liu M, Scalia R, Mehta J, Williams K . Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification. Arterioscler Thromb Vasc Biol. 2012; 32(9):2113-21. PMC: 4568119. DOI: 10.1161/ATVBAHA.112.255471. View

3.
Li W, Choi Y, Lee P, Huh K, Kang Y, Kim H . Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant. 2009; 17(9):1045-59. DOI: 10.3727/096368908786991551. View

4.
Ophelders D, Wolfs T, Jellema R, Zwanenburg A, Andriessen P, Delhaas T . Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia. Stem Cells Transl Med. 2016; 5(6):754-63. PMC: 4878333. DOI: 10.5966/sctm.2015-0197. View

5.
Vahidy F, Schabitz W, Fisher M, Aronowski J . Reporting Standards for Preclinical Studies of Stroke Therapy. Stroke. 2016; 47(10):2435-8. DOI: 10.1161/STROKEAHA.116.013643. View